Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IRON Disc Medicine Inc

7.99 (20.40%)
Jun 14 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,199,838
Bid Price 45.50
Ask Price 47.31
News (6)
Day High 48.45


52 Week Range


Day Low 39.11
Company Name Stock Ticker Symbol Market Type
Disc Medicine Inc IRON NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
7.99 20.40% 47.1478 20:00:00
Open Price Low Price High Price Close Price Prev Close
39.16 39.11 48.45 46.27 39.16
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,680 1,199,838 $ 45.80 $ 54,949,820 - 25.60 - 77.60
Last Trade Time Type Quantity Stock Price Currency
19:57:25 1 $ 46.99 USD

Disc Medicine Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
305.62M 24.14M - 0 -76.43M -3.17 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Disc Medicine News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IRON Message Board. Create One! See More Posts on IRON Message Board See More Message Board Posts

Historical IRON Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week36.6548.4535.6839.21283,93510.5028.64%
1 Month32.3448.4530.6535.46345,29814.8145.79%
3 Months60.7662.6925.6033.69494,406-13.61-22.40%
6 Months60.1777.6025.6046.06390,888-13.02-21.64%
1 Year52.0577.6025.6047.79302,402-4.90-9.42%
3 Years20.8977.6015.0045.16243,61926.26125.70%
5 Years20.8977.6015.0045.16243,61926.26125.70%

Disc Medicine Description

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism.

Your Recent History

Delayed Upgrade Clock